Edge Precision Manufacturing’s Post

Did you know that government grants like STTR and SBIR are the largest sources of funding for early-stage life science startups? These grants are an essential tool for so many, but they also come with some serious strings attached. Learn more in the most recent edition of MichBio's BioMatters Magazine.

Before we get swept away with what's shaping up to be a great summer, be sure to check out the Spring edition of MichBio's BioMatters magazine 😎. This is an INCREDIBLE publication that showcases Michigan's booming biosciences industry. Aurora Patents was honored to be featured in this edition with a piece on Government Grants (SBIR/STTR) and Patent rights. On pages 28-29 in the link below, we write about not only how valuable and necessary these grants are for so many startups, particularly for those in biotech, but also the strings recipients need to be aware of when it comes to things like: ⦿ Fully paid-up, irrevocable licenses for Federal Government (and subcontractor!) usage. ⦿ Sticky implications for licensing when using your own subcontractors instead of W2 employees. ⦿ How march-in rights currently factor into government use and dangerous provisions currently being considered by the government. ⦿ Losing your ownership rights for failing to commercialize or file the correct paperwork on time. #patents #lifesciece #biotech #sbir #sttr #governmentgrants #BayhDole #research #grants #medtech #startups #funding #licensing #invention #biosciences #michiganeconomy #science #ip https://lnkd.in/gcsGzjXn

Yesterday, we held our 'Advances in bio-automation' event in collaboration with Nucleate UK and Bits in Bio. Thank you to everyone who joined us, whether online or in person. The discussion highlighted automation's incredible potential in advancing scientific research and commercialisation. It addressed practical challenges and offered effective implementation strategies for those considering automation for their labs. If you couldn't attend but would like to get the recording of the panel discussion, drop a comment below 👇 #BioTech #DrugDevelopment #LabAutomation

Our CEO, Shahar Keinan, spoke yesterday during the #QuantumComputing sessions at this years BioIT World conference in #Boston about how we are translating chemistry into the language of #QuantumComputers. We use this technology to search a diverse chemical space of over a Nonillion #molecules to find those desired candidates that exhibit the drug-like characteristics to be an effective treatment. If you would like to talk to her about how your team may be able to utilize our Quantum-Aided Drug Design platform to revolutionize your own #DrugDiscovery processes, please do not hesitate to reach out. https://lnkd.in/gbzuQuaR

In the world of #weedscience, so much goes into #research, product development, screening, etc. when it comes to #herbicide innovations. Dr. Arnold Appleby at Oregon State University created this clever “geneaology” to understand industry relationships over time. https://lnkd.in/giXMDDyf #WSWS #herbicides #invasiveplants

🔬 While the science at the heart of Accelerated Biosciences is complex, our approach to business is straightforward. By leveraging our extensive research expertise and in-depth regulatory knowledge, we offer our partners a streamlined path to success. This approach not only saves valuable time but also significantly reduces costs. With us, complexity in science meets simplicity in collaboration. #SimplifyingInnovation #BiotechBusiness

🚀 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭! 🚀 Our researcher Linda Cai will be showcasing her poster titled "Challenges of Bioprocess Scale-Down on an Automated Platform" at the Dechema Himmelfahrtstagung next week! 🧬 Don't miss this opportunity to delve into the complexities of bioprocess scale-down. 👉 https://lnkd.in/ePgYCEr3 #DechemaHimmelfahrtstagung #BioprocessScaleDown #ResearchInsights 🌱🔬

📢 Did you know? Your body contains more bacterial cells than human cells! According to a 2016 study by the Weizmann Institute of Science, our cell count is 56% bacteria—less than previous estimates of 90%. However, bacteria make up just 200g of our body mass, meaning we're over 99.7% human by weight. Understanding the balance between human and bacterial cells can drive innovation in the life sciences, which is why ProcEurope is dedicated to supporting the advancement of research and development in life sciences. Find out more at www.proceurope.com #lifesciences #purchasing #biotech #researchanddevelopment

So many biocatalysis projects end up failing because they were just not meant to be. When it comes to enzyme development, it’s hard to make the right decision without having clarity on the chances of success. Specially, with no reliable data. In the last few months, at ZYMVOL we’ve been envisioning the way to use our prediciting capabilities to solve this issue. And finally, today, we’re presenting #Zymplifier. Zymplifier is our data-driven approach to help all those innovators in the field of green chemistry find out the most promising opportunities in their enzyme development portfolio. Have a look at Zymplifier and start betting on what is most likely to succeed. 👉 https://lnkd.in/d4ACXiQP

In his latest article, Dr Michael Euan Ford at HLK dissects a patent from the European Patent Office to BRAIN Biotech AG for #PreciousMetals recovery from industrial wastes like #FlyAsh or #IncinerationAsh. Read more at: bit.ly/4aYBl6H